Table 1.
Patients who underwent G-CSF therapy
| Case no. | Dose of G-CSF (μg/kg/day) | Age (years)/gender | Diagnosis | Most stenotic level | Surgical procedure | Time of surgery after G-CSF administration (days) | Follow-up period after G-CSF administration (months) |
|---|---|---|---|---|---|---|---|
| 1 | 5 | 61/M | T-OLF | T10–11 | PD (T2–3, T9–11) | 49 | 6 |
| 2 | 5 | 68/M | T-OPLL | T4–5 | PDF (T1–T7) | 10 | 6 |
| 3 | 5 | 51/M | T-OPLL | T1–2 | PDF (C7–T5) | 10 | 6 |
| 4 | 5 | 37/M | T-OPLL | T3–4 | PDF (T1–T10) | 9 | 6 |
| 5 | 5 | 35/M | C- and T-OPLL | C6–7 | PDF (C2–T4) | 115 | 6 |
| 6 | 10 | 46/M | T-OPLL | T7–8 | PDF (T4–T11) | 59 | 6 |
| 7 | 10 | 67/M | C-OPLL | C5–6 | NS | NS | 6 |
| 8 | 10 | 75/M | C-OPLL | C3–4 | PDF (C2–T1) | 49 | 6 |
| 9 | 10 | 64/M | C-OPLL | C3–4 | PDF (C2–T1) | 41 | 6 |
| 10 | 10 | 32/M | T-OPLL | T7–8 | PDF (T4–T12) | 29 | 6 |
| 11 | 10 | 67/M | T-OLF | T11–12 | PD (T10–12) | 33 | 6 |
| 12 | 10 | 46/M | CSM | C5–6 | PD (C3–7) | 94 | 6 |
| 13 | 10 | 66/M | CSM | C4–5 | PD (C3–7) | 73 | 6 |
| 14 | 10 | 67/M | CSM | C4–5 | PDF (C2–T1) | 67 | 6 |
| 15 | 10 | 74/M | CSM | C7–T1 | PD (C7–T1) | 30 | 6 |
M male, T thoracic, OLF ossification of ligamentum flavum, PD posterior decompression, OPLL ossification of the posterior longitudinal ligament, PDF posterior decompression with instrumented fusion, C cervical, NS no surgery